Mark A. Behrendt - Publications

Uro-oncology in the era of social distancing: the principles of patient-centered online consultations during the COVID-19 pandemic.

Journal: Central European journal of urology

Published: June 13, 2020

Diagnostic Laparoscopy and Abdominal Cytology Reliably Detect Peritoneal Metastases in Patients with Urachal Adenocarcinoma.

Journal: Annals of surgical oncology

Published: September 16, 2019

Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 21, 2019

Harnessing New Media Tools in Patient Information.

Journal: European urology

Published: August 22, 2018

Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.

Journal: International journal of cancer

Published: October 29, 2017

Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Journal: Disease markers

Published: July 25, 2017

Genetics and biological markers in urachal cancer.

Journal: Translational andrology and urology

Published: October 28, 2016

Urachal cancer: contemporary review of the pathological, surgical, and prognostic aspects of this rare disease.

Journal: Minerva urologica e nefrologica = The Italian journal of urology and nephrology

Published: November 20, 2015

Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder.

Journal: Current opinion in urology

Published: July 01, 2015

Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder.

Journal: European urology

Published: March 09, 2015